Prevention of interval colorectal cancers: What every clinician needs to know

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 1, 2014, Pages 7-15

  Patel, Swati G ^a   Ahnen, Dennis J ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

ADR; Advanced Neoplasia; CAC; CI; Colonoscopy; CRC; Interval Cancer; IRR; NBI; OR

Indexed keywords

METHYLENE BLUE;

ADVANCED CANCER; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CHROMOENDOSCOPY; COLONOSCOPY; COLORECTAL CANCER; ENDOSCOPIC POLYPECTOMY; ENDOSCOPIST; HUMAN; INTESTINE PREPARATION; PRECANCER; PROSPECTIVE STUDY; RECTUM ADENOMA; RETROSPECTIVE STUDY; RISK FACTOR; SCREENING TEST; COLORECTAL NEOPLASMS; PRECANCEROUS CONDITIONS; PROCEDURES; UTILIZATION;

COLONOSCOPY; COLORECTAL NEOPLASMS; HUMANS; PRECANCEROUS CONDITIONS;

EID: 84890132831     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.04.027     Document Type: Article

References (83)

1. Edwards B.K., Ward E., Kohler B.A., et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010, 116:544-573.
2. Merrill R.M., Anderson A.E. Risk-adjusted colon and rectal cancer incidence rates in the United States. Dis Colon Rectum 2011, 54:1301-1306.
3. Vital signs: colorectal cancer screening, incidence, and mortality-United States, 2002-2010. MMWR Morb Mortal Wkly Rep 2011, 60:884-889. Centers for Disease Control and Prevention.
4. Winawer S.J., Zauber A.G., Ho M.N., et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. NEngl J Med 1993, 329:1977-1981.
5. Zauber A.G., Winawer S.J., O'Brien M.J., et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. NEngl J Med 2012, 366:687-696.
6. Rex D.K., Johnson D.A., Anderson J.C., et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009. Am J Gastroenterol 2009, 104:739-750. [corrected].
7. Levin B., Lieberman D.A., McFarland B., et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008, 134:1570-1595.
8. Baxter N.N., Warren J.L., Barrett M.J., et al. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. JClin Oncol 2012, 30:2664-2669.
9. Doubeni C.A., Weinmann S., Adams K., et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med 2013, 158:312-320.
10. Rabeneck L., Paszat L.F. Circumstances in which colonoscopy misses cancer. Frontline Gastroenterol 2010, 1:52-58.
11. Singh H., Nugent Z., Demers A.A., et al. Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol 2010, 105:2588-2596.
12. Baxter N.N., Sutradhar R., Forbes S.S., et al. Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology 2011, 140:65-72.
13. Cooper G.S., Xu F., Barnholtz Sloan J.S., et al. Prevalence and predictors of interval colorectal cancers in medicare beneficiaries. Cancer 2012, 118:3044-3052.
14. Singh H., Nugent Z., Mahmud S.M., et al. Predictors of colorectal cancer after negative colonoscopy: a population-based study. Am J Gastroenterol 2010, 105:663-673. quiz 674.
15. Brenner H., Chang-Claude J., Seiler C.M., et al. Interval cancers after negative colonoscopy: population-based case-control study. Gut 2012, 61:1576-1582.
16. Greenberg E.R., Baron J.A., Tosteson T.D., et al. Aclinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. NEngl J Med 1994, 331:141-147.
17. Alberts D.S., Martinez M.E., Hess L.M., et al. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. JNatl Cancer Inst 2005, 97:846-853.
18. Alberts D.S., Martinez M.E., Roe D.J., et al. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. NEngl J Med 2000, 342:1156-1162.
19. Baron J.A., Beach M., Mandel J.S., et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. NEngl J Med 1999, 340:101-107.
20. Baron J.A., Cole B.F., Sandler R.S., et al. Arandomized trial of aspirin to prevent colorectal adenomas. NEngl J Med 2003, 348:891-899.
21. Pabby A., Schoen R.E., Weissfeld J.L., et al. Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc 2005, 61:385-391.
22. Schatzkin A., Lanza E., Corle D., et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. NEngl J Med 2000, 342:1149-1155.
23. Yang G., Zheng W., Sun Q.R., et al. Pathologic features of initial adenomas as predictors for metachronous adenomas of the rectum. JNatl Cancer Inst 1998, 90:1661-1665.
24. van Stolk R.U., Beck G.J., Baron J.A., et al. Adenoma characteristics at first colonoscopy as predictors of adenoma recurrence and characteristics at follow-up. The Polyp Prevention Study Group. Gastroenterology 1998, 115:13-18.
25. Loeve F., van Ballegooijen M., Boer R., et al. Colorectal cancer risk in adenoma patients: a nation-wide study. Int J Cancer 2004, 111:147-151.
26. Bertario L., Russo A., Sala P., et al. Predictors of metachronous colorectal neoplasms in sporadic adenoma patients. Int J Cancer 2003, 105:82-87.
27. Bertario L., Russo A., Sala P., et al. Risk of colorectal cancer following colonoscopic polypectomy. Tumori 1999, 85:157-162.
28. Noshirwani K.C., van Stolk R.U., Rybicki L.A., et al. Adenoma size and number are predictive of adenoma recurrence: implications for surveillance colonoscopy. Gastrointest Endosc 2000, 51:433-437.
29. Atkin W.S., Morson B.C., Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. NEngl J Med 1992, 326:658-662.
30. Nusko G., Mansmann U., Kirchner T., et al. Risk related surveillance following colorectal polypectomy. Gut 2002, 51:424-428.
31. Bonithon-Kopp C., Piard F., Fenger C., et al. Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum 2004, 47:323-333.
32. Lieberman D.A., Weiss D.G., Harford W.V., et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology 2007, 133:1077-1085.
33. Winawer S.J., Zauber A.G., O'Brien M.J., et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. NEngl J Med 1993, 328:901-906.
34. Robertson D.J., Greenberg E.R., Beach M., et al. Colorectal cancer in patients under close colonoscopic surveillance. Gastroenterology 2005, 129:34-41.
35. Saini S.D., Kim H.M., Schoenfeld P. Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review. Gastrointest Endosc 2006, 64:614-626.
36. Martinez M.E., Baron J.A., Lieberman D.A., et al. Apooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. Gastroenterology 2009, 136:832-841.
37. Robertson D., Lieberman D., Winawer S.J., et al. Interval cancer after total colonoscopy: results from a pooled analysis of eight studies. Gastroenterology 2008, 134:111-112.
38. Pohl H., Robertson D.J. Colorectal cancers detected after colonoscopy frequently result from missed lesions. Clin Gastroenterol Hepatol 2010, 8:858-864.
39. Kahi C.J., Hewett D.G., Norton D.L., et al. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol 2011, 9:42-46.
40. van Rijn J.C., Reitsma J.B., Stoker J., et al. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol 2006, 101:343-350.
41. Pickhardt P.J., Choi J.R., Hwang I., et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. NEngl J Med 2003, 349:2191-2200.
42. Pohl H., Srivastava A., Bensen S.P., et al. Incomplete polyp resection during colonoscopy-results of the Complete Adenoma Resection (CARE) study. Gastroenterology 2013, 144:74-80e1.
43. Sawhney M.S., Farrar W.D., Gudiseva S., et al. Microsatellite instability in interval colon cancers. Gastroenterology 2006, 131:1700-1705.
44. Arain M.A., Sawhney M., Sheikh S., et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol 2010, 105:1189-1195.
45. Shaukat A., Arain M., Anway R., et al. Is KRAS mutation associated with interval colorectal cancers?. Dig Dis Sci 2012, 57:913-917.
46. Jass J.R. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007, 50:113-130.
47. Rex D.K., Ahnen D.J., Baron J.A., et al. Serrated lesions of thecolorectum: review and recommendations from an expert panel. Am J Gastroenterol 2012, 107:1315-1329. quiz 1314, 1330.
48. Kaminski M.F., Regula J., Kraszewska E., et al. Quality indicators for colonoscopy and the risk of interval cancer. NEngl J Med 2010, 362:1795-1803.
49. Wang H.S., Pisegna J., Modi R., et al. Adenoma detection rate is necessary but insufficient for distinguishing high versus low endoscopist performance. Gastrointest Endosc 2013, 77:71-78.
50. Williams J.E., Holub J.L., Faigel D.O. Polypectomy rate is a valid quality measure for colonoscopy: results from a national endoscopy database. Gastrointest Endosc 2012, 75:576-582.
51. Siddiqui A.A., Yang K., Spechler S.J., et al. Duration of the interval between the completion of bowel preparation and the start of colonoscopy predicts bowel-preparation quality. Gastrointest Endosc 2009, 69:700-706.
52. Enestvedt B.K., Tofani C., Laine L.A., et al. 4-Liter split-dose polyethylene glycol is superior to other bowel preparations, based on systematic review and meta-analysis. Clin Gastroenterol Hepatol 2012, 10:1225-1231.
53. Barclay R.L., Vicari J.J., Doughty A.S., et al. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. NEngl J Med 2006, 355:2533-2541.
54. Gellad Z.F., Weiss D.G., Ahnen D.J., et al. Colonoscopy withdrawal timeand risk of neoplasia at 5 years: results from VA Cooperative Studies Program 380. Am J Gastroenterol 2010, 105:1746-1752.
55. Lee R.H., Tang R.S., Muthusamy V.R., et al. Quality of colonoscopy withdrawal technique and variability in adenoma detection rates (with videos). Gastrointest Endosc 2011, 74:128-134.
56. Shaukat A., Oancea C., Bond J.H., et al. Variation in detection of adenomas and polyps by colonoscopy and change over time with a performance improvement program. Clin Gastroenterol Hepatol 2009, 7:1335-1340.
57. Sawhney M.S., Cury M.S., Neeman N., et al. Effect of institution-wide policy of colonoscopy withdrawal time > or= 7 minutes on polyp detection. Gastroenterology 2008, 135:1892-1898.
58. Barclay R.L., Vicari J.J., Greenlaw R.L. Effect of a time-dependent colonoscopic withdrawal protocol on adenoma detection during screening colonoscopy. Clin Gastroenterol Hepatol 2008, 6:1091-1098.
59. Coe S.G., Crook J.E., Diehl N.N., et al. An endoscopic quality improvement program improves detection of colorectal adenomas. Am J Gastroenterol 2013, 108:219-226.
60. Ng S.C., Tsoi K.K., Hirai H.W., et al. The efficacy of cap-assisted colonoscopy in polyp detection and cecal intubation: a meta-analysis ofrandomized controlled trials. Am J Gastroenterol 2012, 107:1165-1173.
61. Westwood D.A., Alexakis N., Connor S.J. Transparent cap-assisted colonoscopy versus standard adult colonoscopy: a systematic review and meta-analysis. Dis Colon Rectum 2012, 55:218-225.
62. Rastogi A., Bansal A., Rao D.S., et al. Higher adenoma detection rates with cap-assisted colonoscopy: a randomised controlled trial. Gut 2012, 61:402-408.
63. Rex D.K. Narrow-band imaging without optical magnification for histologic analysis of colorectal polyps. Gastroenterology 2009, 136:1174-1181.
64. Rastogi A., Keighley J., Singh V., et al. High accuracy of narrow band imaging without magnification for the real-time characterization of polyp histology and its comparison with high-definition white light colonoscopy: a prospective study. Am J Gastroenterol 2009, 104:2422-2430.
65. Ignjatovic A., Thomas-Gibson S., East J.E., et al. Development and validation of a training module on the use of narrow-band imaging in differentiation of small adenomas from hyperplastic colorectal polyps. Gastrointest Endosc 2011, 73:128-133.
66. Pasha S.F., Leighton J.A., Das A., et al. Comparison of the yield and miss rate of narrow band imaging and white light endoscopy in patients undergoing screening or surveillance colonoscopy: a meta-analysis. Am J Gastroenterol 2012, 107:363-370. quiz 371.
67. Adler A., Aminalai A., Aschenbeck J., et al. Latest generation, wide-angle, high-definition colonoscopes increase adenoma detection rate. Clin Gastroenterol Hepatol 2012, 10:155-159.
68. Siersema P.D., Rastogi A., Leufkens A.M., et al. Retrograde-viewing device improves adenoma detection rate in colonoscopies for surveillance and diagnostic workup. World J Gastroenterol 2012, 18:3400-3408.
69. Rex D.K., Petrini J.L., Baron T.H., et al. Quality indicators for colonoscopy. Am J Gastroenterol 2006, 101:873-885.
70. Singh H., Bay D., Ip S., et al. Pathological reassessment of hyperplastic colon polyps in a city-wide pathology practice: implications for polyp surveillance recommendations. Gastrointest Endosc 2012, 76:1003-1008.
71. Cipolletta L., Bianco M.A., Garofano M.L., et al. Can magnification endoscopy detect residual adenoma after piecemeal resection of large sessile colorectal lesions to guide subsequent treatment? Aprospective single-center study. Dis Colon Rectum 2009, 52:1774-1779.
72. Brooker J.C., Saunders B.P., Shah S.G., et al. Treatment with argon plasma coagulation reduces recurrence after piecemeal resection of large sessile colonic polyps: a randomized trial and recommendations. Gastrointest Endosc 2002, 55:371-375.
73. Lieberman D.A., Rex D.K., Winawer S.J., et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012, 143:844-857.
74. Khashab M., Eid E., Rusche M., et al. Incidence and predictors of "late" recurrences after endoscopic piecemeal resection of large sessile adenomas. Gastrointest Endosc 2009, 70:344-349.
75. Quirke P., Risio M., Lambert R., et al. Quality assurance in pathology in colorectal cancer screening and diagnosis-European recommendations. Virchows Arch 2011, 458:1-19.
76. Nicolas-Perez D., Parra-Blanco A., Gimeno-Garcia A.Z., et al. Risk factors associated with colorectal flat adenoma detection. Eur J Gastroenterol Hepatol 2013, 25:302-308.
77. Patel S.G., Ahnen D.J. Isn't it time to stop talking about colonoscopy quality and start doing something about it?. Dig Dis Sci 2011, 56:2776-2779.
78. American Association for the Study of Liver Diseases, American College of Gastroenterology, American Gastroenterological Association Institute, et al. The gastroenterology core curriculum, third edition. Gastroenterology 2007, 132:2012-2018.
79. Training C., Sedlack R.E., Shami V.M., et al. Colonoscopy core curriculum. Gastrointest Endosc 2012, 76:482-490.
80. Spier B.J., Benson M., Pfau P.R., et al. Colonoscopy training in gastroenterology fellowships: determining competence. Gastrointest Endosc 2010, 71:319-324.
81. Sedlack R.E. Training to competency in colonoscopy: assessing and defining competency standards. Gastrointest Endosc 2011, 74:355-366e1-2.
82. Patel S., Ahnen D. Screening for colon polyps and cancer. Epidemiologic studies in cancer prevention and screening 2013, Vol 79:233-261. Springer, New York.
83. Shaukat A., Arain M., Thaygarajan B., et al. Is BRAF mutation associated with interval colorectal cancers?. Dig Dis Sci 2010, 55:2352-2356.